Nivolumab vs Tacrolimus

## Nivolumab vs Tacrolimus: Overview

This comparison examines the pharmacological differences between **Nivolumab** and **Tacrolimus**.

## Mechanism of Action

**Nivolumab**: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

**Tacrolimus**: Calcineurin inhibitor binding FKBP12; suppresses IL-2 transcription.

## Pharmacokinetics

**Half-life**: Nivolumab — 27 days; Tacrolimus — 12 hours.

## Chemical Properties

**Molecular Formula**: Nivolumab — N/A; Tacrolimus — C44H69NO12.

**Molecular Weight**: Nivolumab — N/A; Tacrolimus — 804.0180 g/mol.

**Type**: Nivolumab — Antibody; Tacrolimus — Small molecule.